Meng‐Lei Huan

992 total citations
36 papers, 824 citations indexed

About

Meng‐Lei Huan is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Meng‐Lei Huan has authored 36 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Biomaterials and 8 papers in Biomedical Engineering. Recurrent topics in Meng‐Lei Huan's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Meng‐Lei Huan is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Meng‐Lei Huan collaborates with scholars based in China, United States and India. Meng‐Lei Huan's co-authors include Siyuan Zhou, Bang‐Le Zhang, Qibing Mei, Zenghui Teng, Han Cui, Daozhou Liu, Miao Liu, Ning Wan, Yiyang Jia and Zhifu Yang and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Agricultural and Food Chemistry.

In The Last Decade

Meng‐Lei Huan

35 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng‐Lei Huan China 16 323 187 144 77 71 36 824
Piergiorgio Pettazzoni Italy 10 316 1.0× 138 0.7× 100 0.7× 60 0.8× 50 0.7× 13 772
Haining Tan China 17 360 1.1× 134 0.7× 117 0.8× 69 0.9× 63 0.9× 51 888
Elham Ghasemipour Afshar Iran 13 410 1.3× 162 0.9× 179 1.2× 72 0.9× 29 0.4× 15 921
Prashanth K.B. Nagesh United States 17 429 1.3× 317 1.7× 254 1.8× 126 1.6× 42 0.6× 32 1.1k
Qunyou Tan China 20 438 1.4× 170 0.9× 140 1.0× 122 1.6× 37 0.5× 48 1.0k
Bilan Wang China 13 257 0.8× 340 1.8× 161 1.1× 67 0.9× 28 0.4× 14 878
Dhanalekshmi Unnikrishnan Meenakshi India 21 450 1.4× 143 0.8× 118 0.8× 47 0.6× 42 0.6× 45 1.3k
Davoud Jafari-Gharabaghlou Iran 17 355 1.1× 204 1.1× 152 1.1× 122 1.6× 30 0.4× 42 871
Shih-Chang Tsai Taiwan 16 445 1.4× 113 0.6× 59 0.4× 78 1.0× 45 0.6× 24 805

Countries citing papers authored by Meng‐Lei Huan

Since Specialization
Citations

This map shows the geographic impact of Meng‐Lei Huan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Lei Huan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Lei Huan more than expected).

Fields of papers citing papers by Meng‐Lei Huan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Lei Huan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Lei Huan. The network helps show where Meng‐Lei Huan may publish in the future.

Co-authorship network of co-authors of Meng‐Lei Huan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Lei Huan. A scholar is included among the top collaborators of Meng‐Lei Huan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Lei Huan. Meng‐Lei Huan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Tingting, et al.. (2025). Tumor-targeted nano-delivery system of camptothecin nanocrystals for the effective treatment of triple negative breast cancer. Journal of Pharmaceutical Sciences. 114(10). 103951–103951.
2.
Cheng, Ying, Zhifu Yang, Qifeng Ji, et al.. (2024). Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction. Journal of Nanobiotechnology. 22(1). 93–93. 12 indexed citations
3.
Huan, Meng‐Lei, et al.. (2024). Construction of the pulmonary bio-adhesive delivery system of nintedanib nanocrystalline for effective treatment of pulmonary fibrosis. International Journal of Pharmaceutics. 660. 124302–124302. 3 indexed citations
4.
Huan, Meng‐Lei, et al.. (2024). Nonviral genetic manipulation system with microenvironmental cascade sensitivity for the treatment of TNBC-associated metastatic bone tumor. Chemical Engineering Journal. 499. 156162–156162. 1 indexed citations
5.
Huan, Meng‐Lei, et al.. (2023). Construction of mPEI/pGPX4 gene therapeutic system for the effective treatment of acute lung injury. Nanotechnology. 34(33). 335101–335101. 3 indexed citations
6.
Li, Jiaxin, et al.. (2023). Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer. International Journal of Pharmaceutics. 635. 122755–122755. 5 indexed citations
7.
Huan, Meng‐Lei, et al.. (2023). Tumor targeted combination therapeutic system for the effective treatment of drug resistant triple negative breast cancer. International Journal of Pharmaceutics. 636. 122821–122821. 12 indexed citations
8.
9.
Zhang, Yaowen, Hua Li, Wei Wang, et al.. (2022). The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis. Pharmacology & Therapeutics. 234. 108117–108117. 21 indexed citations
10.
Liu, Daozhou, Qifeng Ji, Ying Cheng, et al.. (2022). Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice. Journal of Nanobiotechnology. 20(1). 256–256. 39 indexed citations
11.
Zhang, Yaowen, et al.. (2021). The Regulatory Role and Mechanism of Autophagy in Energy Metabolism-Related Hepatic Fibrosis. SSRN Electronic Journal. 2 indexed citations
12.
Cui, Han, Meng‐Lei Huan, Weiliang Ye, et al.. (2017). Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance. Molecular Pharmaceutics. 14(3). 746–756. 38 indexed citations
13.
Jing, Ziwei, Yiyang Jia, Ning Wan, et al.. (2016). Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials. 84. 276–285. 91 indexed citations
14.
Zhao, Yuan, Meng‐Lei Huan, Miao Liu, et al.. (2016). Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Scientific Reports. 6(1). 35267–35267. 96 indexed citations
15.
Huan, Meng‐Lei, et al.. (2015). Novel Cholesterol-Based Cationic Lipids as Transfecting Agents of DNA for Efficient Gene Delivery. International Journal of Molecular Sciences. 16(3). 5666–5681. 31 indexed citations
16.
Liu, Hongfei, Ning Wan, Meng‐Lei Huan, et al.. (2014). Enhanced water-soluble derivative of PC407 as a novel potential COX-2 inhibitor injectable formulation. Bioorganic & Medicinal Chemistry Letters. 24(20). 4794–4797. 2 indexed citations
17.
Huan, Meng‐Lei, Bang‐Le Zhang, Zenghui Teng, et al.. (2012). In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin. PLoS ONE. 7(9). e44116–e44116. 23 indexed citations
18.
Wang, Xiaojuan, Han Cui, Rong Wang, et al.. (2012). Metabolism and Pharmacokinetic Study of Ardipusilloside I in Rats. Planta Medica. 78(6). 565–574. 6 indexed citations
19.
Huan, Meng‐Lei, Han Cui, Zenghui Teng, et al.. (2012). In VivoAnti-Tumor Activity of a New Doxorubicin Conjugateviaα-Linolenic Acid. Bioscience Biotechnology and Biochemistry. 76(8). 1577–1579. 18 indexed citations
20.
Zhou, Siyuan, Bang‐Le Zhang, Zenghui Teng, et al.. (2009). A new natural angelica polysaccharide based colon-specific drug delivery system. Journal of Pharmaceutical Sciences. 98(12). 4756–4768. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026